[Red Blood Cell Transfusion - Indications, Informed Consent and Associated Risks]

Area of Science:

• Hematology
• Transfusion Medicine

Background:

• Red blood cell (RBC) transfusions are critical for treating anemic tissue hypoxia.
• In 2022, Germany performed over 3.2 million RBC transfusions, predominantly in surgical settings.
• Appropriate RBC use requires understanding indications, handling, documentation, and transfusion-associated adverse events.

Purpose of the Study:

• To emphasize the importance of appropriate red blood cell transfusion practices.
• To highlight the risks associated with anemia and blood loss, specifically the imbalance between oxygen supply and demand.
• To advocate for targeted, rational (restrictive) transfusion strategies.

Main Methods:

• Review of current evidence on RBC transfusion indications.
• Emphasis on proper handling, documentation, and management of adverse events.
• Application of physiological transfusion triggers for decision-making.

Main Results:

• Inappropriate RBC use can lead to adverse events and ineffective treatment.
• Blood loss significantly increases the risk of oxygen supply-demand imbalance.
• Restrictive transfusion strategies based on physiological triggers are effective.

Conclusions:

• Appropriate RBC transfusion is essential for preventing and treating anemic tissue hypoxia.
• Knowledge of transfusion guidelines, risks, and management is crucial for healthcare providers.
• Targeted, restrictive transfusion practices help avoid organ injury and optimize patient outcomes.